Notice to attend the Annual General Meeting in Umecrine Cognition AB

18 May 2022 - 09:45

The shareholders in Umecrine Cognition AB, reg. no. 556698-3655, are hereby given notice to attend the annual general meeting at 10:00 a.m. on Friday 17 June 2022 at Setterwalls Advokatbyrå’s offices at Sturegatan 10 in Stockholm, Sweden. Registration for the meeting commences at 9:30 a.m.

Aktieägarna i Umecrine Cognition AB, 556698-3655, kallas härmed till årsstämma fredagen den 17 juni 2022 klockan 10.00 i Setterwalls Advokatbyrås lokaler på adress Sturegatan 10 i Stockholm. Inregistrering till stämman börjar klockan 9.30.

The complete Notice can be found on /Kallelsen i sin helhet finns på sidan:

Provided by: MFN
Nasdaq First North GM Stockholm (Sweden)
Umecrine Cognition AB
Umecrine Cognition is developing pharmaceuticals against neurological disorders in the central nervous system, CNS that are caused by endogenous CNS-active steroids (neurosteroids)....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More